Management of the Pregnant ICU Patient

Critically ill pregnant women require management by experienced clinicians. Maternal mortality and serious morbidity may be avoided if serious complications are recognized early and managed appropriately. This review reflects published evidence and, where this is lacking, the experience of a tertiary obstetric intensive care unit. Severe preeclampsia is the most common obstetric indication for intensive care admission, and one of the major causes of maternal death throughout the world. It may develop insidiously or have a fulminant onset, and may result in multiorgan failure. Neurologic, respiratory, renal, and liver dysfunction may occur; eclampsia is the single most lethal complication. Critical care of women with severe preeclampsia requires an understanding of the underlying pathophysiology, and in particular, the distinct hemodynamic changes that characterize this disorder. The principles of hemodynamic management include control of severe hypertension and volume expansion. Pulmonary artery catheterization is indicated in selected women. Left ventricular filling pressures may rise rapidly in response to small fluid challenges, with the result that these patients are very susceptible to pulmonary edema. Right-sided filling pressures are not similarly affected; therefore, central venous pressure measurements cannot be used to guide fluid management. Other major causes of maternal mortality are cardiac disease, obstetric hemorrhage, sepsis, pulmonary embolism, and amniotic fluid embolism. Air embolism may occur in relation to normal and complicated delivery, and is most likely underdiagnosed. These conditions also require prompt and effective management, and may necessitate admission to intensive care.

[1]  P. Bergsjø Handbook of Obstetric Medicine , 2003 .

[2]  J. Higgins,et al.  Blood-pressure measurement and classification in pregnancy , 2001, The Lancet.

[3]  W. Gilbert,et al.  The safety and utility of pulmonary artery catheterization in severe preeclampsia and eclampsia. , 2000, American journal of obstetrics and gynecology.

[4]  I. Greer,et al.  Non-haemorrhagic obstetric shock. , 2000, Bailliere's best practice & research. Clinical obstetrics & gynaecology.

[5]  J. Bonnar Massive obstetric haemorrhage. , 2000 .

[6]  R. V. van Schijndel,et al.  LACK OF AGREEMENT BETWEEN CENTRAL VENOUS PRESSURE AND PULMONARY CAPILLARY WEDGE PRESSURE IN PREECLAMPSIA , 2000, Hypertension in pregnancy.

[7]  A W Halligan,et al.  Comparison of auscultatory and oscillometric automated blood pressure monitors in the setting of preeclampsia. , 1999, American journal of obstetrics and gynecology.

[8]  J. Ibdah,et al.  Inherited long-chain 3-hydroxyacyl-CoA dehydrogenase deficiency and a fetal-maternal interaction cause maternal liver disease and other pregnancy complications. , 1999, Seminars in perinatology.

[9]  I. Sargent,et al.  Preeclampsia: an excessive maternal inflammatory response to pregnancy. , 1999, American journal of obstetrics and gynecology.

[10]  E. Coetzee,et al.  A randomised controlled trial of intravenous magnesium sulphate versus placebo in the management of women with severe pre‐eclampsia , 1998, British journal of obstetrics and gynaecology.

[11]  M. Belfort,et al.  Two‐Dimensional Echocardiography and Doppler Ultrasound in Managing Obstetric Patients , 1997, Obstetrics and gynecology.

[12]  M. O'Day Cardio-respiratory physiological adaptation of pregnancy. , 1997, Seminars in perinatology.

[13]  E. Rackow Pulmonary Artery Catheter Consensus Conference. , 1997, Critical care medicine.

[14]  C. Graves,et al.  Use of the pulmonary artery catheter in severe preeclampsia: a review. , 1996, Obstetrical & gynecological survey.

[15]  L. Duley,et al.  Role of Magnesium Sulfate in Seizure Prevention in Patients with Eclampsia and Pre-Eclampsia , 1996, Drug safety.

[16]  J. Ward,et al.  Management of pre-eclampsia. , 1996, British journal of anaesthesia.

[17]  B A Peretz,et al.  Gas embolism in obstetrics and gynecology. A review. , 1996, The Journal of reproductive medicine.

[18]  The Surfaxin-Lavage for Mas Trial Group Which anticonvulsant for women with eclampsia? Evidence from the Collaborative Eclampsia Trial , 1995, The Lancet.

[19]  R. Collins,et al.  WHICH ANTICONVULSANT FOR WOMEN WITH ECLAMPSIA - EVIDENCE FROM THE COLLABORATIVE ECLAMPSIA TRIAL , 1995 .

[20]  T. Porter,et al.  Amniotic fluid embolism: analysis of the national registry. , 1995, American journal of obstetrics and gynecology.

[21]  L. Peeters,et al.  Renal hemodynamics and volume homeostasis in pregnancy. , 1994, Obstetrical & gynecological survey.

[22]  B. Sibai,et al.  CONSERVATIVE MANAGEMENT OF SEVERE PREECLAMPSIA REMOTE FROM TERM , 1994, Obstetrics and gynecology.

[23]  G. Saade,et al.  Rapid echocardiographic assessment of left and right heart hemodynamics in critically ill obstetric patients. , 1994, American journal of obstetrics and gynecology.

[24]  G. Saade,et al.  The oxygen consumption/oxygen delivery curve in severe preeclampsia: evidence for a fixed oxygen extraction state. , 1993, American journal of obstetrics and gynecology.

[25]  C. Redman,et al.  Management of pre-eclampsia , 1993, The Lancet.

[26]  J. Barton,et al.  Adult respiratory distress syndrome in pregnancy. , 1992, American journal of obstetrics and gynecology.

[27]  M. Belfort,et al.  Respiratory function in severe gestational proteinuric hypertension: the effects of rapid volume expansion and subsequent vasodilatation with verapamil , 1991, British journal of obstetrics and gynaecology.

[28]  M. James,et al.  Attenuation of the pressor response to tracheal intubation in hypertensive proteinuric pregnant patients by lignocaine, alfentanil and magnesium sulphate. , 1991, British journal of anaesthesia.

[29]  M. Druzin,et al.  Are Doppler‐Detected Venous Emboli During Cesarean Section Air Emboli? , 1990, Anesthesia and analgesia.

[30]  D. Cotton,et al.  Effects of low‐dose dopamine therapy in the oliguric patient with preeclampsia , 1989, American journal of obstetrics and gynecology.

[31]  L. M. Mayorga,et al.  Magnesium Plus Nifedipine: Potentiation of Hypotensive Effect in Preeclampsia? , 1988, American journal of obstetrics and gynecology.

[32]  S. Clark,et al.  Clinical indications for pulmonary artery catheterization in the patient with severe preeclampsia. , 1988, American journal of obstetrics and gynecology.

[33]  L. Weinstein Syndrome of hemolysis, elevated liver enzymes, and low platelet count: a severe consequence of hypertension in pregnancy. , 1982, American journal of obstetrics and gynecology.

[34]  A. Bonomo,et al.  [Septic shock in pregnancy]. , 1979, Minerva ginecologica.

[35]  B. Dawson THE PREVENTION OF ECLAMPSIA , 1953, The Journal of obstetrics and gynaecology of the British Empire.

[36]  MRCOG Examination,et al.  Royal College of Obstetricians and Gynaecologists , 1952, The Journal of obstetrics and gynaecology of the British Empire.

[37]  Report of the National High Blood Pressure Education Program Working Group on High Blood Pressure in Pregnancy. , 2000, American journal of obstetrics and gynecology.

[38]  P. Rinaldo,et al.  Liver disease in pregnancy. , 1997, The New England journal of medicine.

[39]  C. Sprung,et al.  Pulmonary Artery Catheter Consensus conference: consensus statement. , 1997, Critical care medicine.

[40]  M. Oppenheimer,et al.  Gas embolism. , 1947, Proceedings. American Federation for Clinical Research.